🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

P. Kelly Marcom

Duke University

ORCID: 0000-0001-5302-6368

Also affiliated with Duke Medical Center

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile
2.4Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis

Nature Cancer(2022)10.1038/s43018-022-00491-x
Top 9%
2.4DataRank
Top 9%114 citations

Toshinori Hinoue, Gregory Wheeler, Benjamin Kelly, Ana C. Garrido-Castro, Tomás Pascual +53 more

Papers

Driven by 13 papers — median percentile 91. Top paper: “Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis”.

Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis

Nature Cancer(2022)10.1038/s43018-022-00491-x
Top 9%
2.4DataRank
Top 9%114 citations

Toshinori Hinoue, Gregory Wheeler, Benjamin Kelly, Ana C. Garrido-Castro, Tomás Pascual +53 more

Evaluation of Alisertib Alone or Combined With Fulvestrant in Patients With Endocrine-Resistant Advanced Breast Cancer

JAMA Oncology(2023)10.1001/jamaoncol.2022.7949
N/A
1.4DataRank · unranked
52 citations

Vera J. Suman, Antonino B. D’Assoro, Jodi M. Carter, Karthik V. Giridhar, Brendan P. McMenomy +18 more

Multiplatform Analysis of Primary and Metastatic Breast Tumors from the AURORA US Network identifies microenvironment and epigenetics drivers of metastasis

Research Square(2022)10.21203/rs.3.rs-1221704/v1
N/A
0.165DataRank · unranked
2 citations

Susana García‐Recio, Toshinori Hinoue4, Gregory Wheeler, Benjamin Kelly, Ana C. Garrido-Castro +49 more

TBCRC 018: phase II study of iniparib in combination with irinotecan to treat progressive triple negative breast cancer brain metastases

UNC Libraries(2020)10.17615/bgrr-9v25
N/A
0DataRank · unranked
0 citations

Anna Maria Storniolo, Vered Stearns, Vandana G. Abramson, Joel S. Parker, Catherine Van Poznak +19 more

TBCRC 001: Randomized Phase II Study of Cetuximab in Combination With Carboplatin in Stage IV Triple-Negative Breast Cancer

UNC Libraries(2020)10.17615/yrss-qx89
N/A
0DataRank · unranked
0 citations

Charles M. Perou, Madlyn Ferraro, Mothaffar F. Rimawi, Wing‐Keung Chiu, Antonio C. Wolff +15 more

Chemotherapy-related amenorrhea after adjuvant paclitaxel–trastuzumab (APT trial)

UNC Libraries(2020)10.17615/e33z-ag80
N/A
0DataRank · unranked
0 citations

Harold J. Burstein, Lisa A. Carey, Antonio C. Wolff, Sara M. Tolaney, P. Kelly Marcom +15 more

Evaluation of established breast cancer risk factors as modifiers of BRCA1 or BRCA2: a multi-center case-only analysis

UNC Libraries(2020)10.17615/7epw-8t59
N/A
0DataRank · unranked
0 citations

Eunjung Lee, Patricia G. Moorman, Dianne M. Finkelstein, P. Kelly Marcom, Banu Arun +15 more

The Use of Bayesian Hierarchical Models for Adaptive Randomization in Biomarker-Driven Phase II Studies

UNC Libraries(2020)10.17615/8tqa-vs28
N/A
0DataRank · unranked
0 citations

Joseph G. Ibrahim, Charles M. Perou, Lisa A. Carey, P. Kelly Marcom, William T. Barry

Exploring homologous recombination deficiency thresholds for predicting response to platinum-based treatment in triple negative breast cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.525
N/A
0DataRank · unranked
0 citations

Lauren Lenz, Elizabeth S. Cogan, Erica L. Mayer, Virginia Kaklamani, Vered Stearns +15 more

Patient‐reported causes of distress predict disparities in time to evaluation and time to treatment after breast cancer diagnosis

Cancer(2020)10.1002/cncr.33310
N/A
0DataRank · unranked
39 citations

Yi Ren, Ilona Stashko, Steve Power, Madeline Thornton, P. Kelly Marcom +3 more

Returning Individual-Level Urgent or Emergent Research Results to Participants: The Project Baseline Health Study Experience

American Journal of Medicine Open(2025)10.1016/j.ajmo.2025.100092
N/A
0DataRank · unranked
0 citations

Brooke L Heidenfelder, Lydia Coulter Kwee, Fátima Rodríguez, Ranee Chatterjee, Kishan S. Parikh +21 more

Adherence to Recommended Risk Management among Unaffected Women with a BRCA Mutation

UNC Libraries(2020)10.17615/47kv-st87
N/A
0DataRank · unranked
3 citations

P. Kelly Marcom, Nora Horick, Joellen M. Schildkraut, Celette Sugg Skinner, Kristi Wiggins +3 more

Quantitative assessment of distant recurrence risk in early stage breast cancer using a nonlinear combination of pathological, clinical and imaging variables

Journal of Biophotonics(2020)10.1002/jbio.201960235
N/A
0DataRank · unranked
1 citations

Erika Chelales, Roujia Wang, Amanda Schulman, Jennifer E. Gallagher, Rachel A. Greenup +6 more